Sleep deprivation is associated with risk of atherosclerosis in adults: JAHA

Published Date: 17 Feb 2023

United States: Infrequent sleep, particularly chronic sleep, in adults aged 45 and older is associated with numerous measures of...

Read Full News

Latest News

BEACON: Positive Results Announced for Briquilimab in Chronic Spontaneous Urticaria

BEACON: Positive Results Announced for Briquilimab in Chronic Spontaneous Urticaria

Family Quality of Life Burden in CSU Increased by Lack of Disease Control

Family Quality of Life Burden in CSU Increased by Lack of Disease Control

Upadacitinib Superior to 4 Other JAKi Monotherapies for Atopic Dermatitis

Upadacitinib Superior to 4 Other JAKi Monotherapies for Atopic Dermatitis

Q4 2025 Recap: Dermatology News and Updates

Q4 2025 Recap: Dermatology News and Updates

Racial Disparities in Persistent Chemotherapy-Induced Alopecia Observed in Women

Racial Disparities in Persistent Chemotherapy-Induced Alopecia Observed in Women

6 Dermatology Headlines You Missed in December 2025

6 Dermatology Headlines You Missed in December 2025

Todays Updates

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Todays Updates

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Latest News

BEACON: Positive Results Announced for Briquilimab in Chronic Spontaneous Urticaria

Family Quality of Life Burden in CSU Increased by Lack of Disease Control

Upadacitinib Superior to 4 Other JAKi Monotherapies for Atopic Dermatitis

Q4 2025 Recap: Dermatology News and Updates

Racial Disparities in Persistent Chemotherapy-Induced Alopecia Observed in Women

6 Dermatology Headlines You Missed in December 2025

News All Time

Nemolizumab Rapidly Relieves Itch in Atopic Dermatitis, Prurigo Nodularis

Nemolizumab Rapidly Relieves Itch in Atopic Dermatitis, Prurigo Nodularis

Phase 3 SCALP Study on Clascoterone for Androgenetic Alopecia, With Maria Hordinsky, MD

Phase 3 SCALP Study on Clascoterone for Androgenetic Alopecia, With Maria Hordinsky, MD

Vixarelimab Demonstrates Rapid, Sustained Clinical Benefits in Prurigo Nodularis

Vixarelimab Demonstrates Rapid, Sustained Clinical Benefits in Prurigo Nodularis

Once-Daily Oral Zasocitinib Delivers Strong Phase 3 Efficacy in Plaque Psoriasis

Once-Daily Oral Zasocitinib Delivers Strong Phase 3 Efficacy in Plaque Psoriasis

REZOLVE-AA: Phase 2b Data Released on Rezpegaldesleukin for Alopecia Areata

REZOLVE-AA: Phase 2b Data Released on Rezpegaldesleukin for Alopecia Areata

Special Report: Reframing Skin Pain in Atopic Dermatitis Mona Shahriari, MD, FAAD, Andrew Mastro, MS, PA-C

This video explores skin pain as a key symptom of atopic dermatitis and reviews clinical trial data with JAK inhibitors.

Skin of Color Savvy: Winter Skin Care for Patients of Color, With Heather Woolery-Lloyd, MD, and Aderonke Obayomi, MD, MPH

Skin of Color Savvy: Winter Skin Care for Patients of Color, With Heather Woolery-Lloyd, MD, and Aderonke Obayomi, MD, MPH

Addictive Behaviors Linked with Chronic Skin Diseases Such as HS, Psoriasis

Addictive Behaviors Linked with Chronic Skin Diseases Such as HS, Psoriasis

Prurigo Nodularis Linked to Increased Risk of Malignancy, Especially Skin Cancers

Prurigo Nodularis Linked to Increased Risk of Malignancy, Especially Skin Cancers

Imsidolimab’s Biologics License Application for Treatment of GPP Submitted to FDA

Imsidolimab’s Biologics License Application for Treatment of GPP Submitted to FDA

Dupilumab Shows Greatest Rate of 2-Year Drug Survival Among Atopic Dermatitis Drugs

Dupilumab Shows Greatest Rate of 2-Year Drug Survival Among Atopic Dermatitis Drugs

Tips on Patient Communication in Dermatology, With Kassandra Holzem, MD Kassandra Holzem, MD

Holzem spoke in this interview about several additional highlights from her session at SDPA Fall regarding red flags in dermatology and when to admit from the clinic.

Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed

Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed

FDA Proposes Expanding Active Ingredient List for Sunscreens

FDA Proposes Expanding Active Ingredient List for Sunscreens

Apremilast Effective Treatment for Moderate to Severe Genital Psoriasis at 32 Weeks

Apremilast Effective Treatment for Moderate to Severe Genital Psoriasis at 32 Weeks

Mild to Moderate Psoriasis Linked with Indicators of Suboptimal Treatment, Disease Control

Mild to Moderate Psoriasis Linked with Indicators of Suboptimal Treatment, Disease Control

Recommended News For You

Children with cancer experience much less pain at home when using a pain monitoring app.

Slowdown in progress found with cancer survival in England and Wales

Obesity-associated cancers tripled nationwide over past two decades

La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.

A video animation guide to assist young people who are fatigued from cancer.

Screening tests that are non-invasive show promise in detecting colorectal cancer.

How the skin cancer virus outperforms the replication of host cells.

Recommended Articles For You

Bridging the Global Divide: Enhancing Psychosocial Care for Cancer Survivors Across Income Settings 

Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans 

Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma 

Emerging and Innovative Therapies in Cancer Treatment and Post-Surgical Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care

2.

Cancer during young adulthood carries long-term mental toll, study finds

3.

Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers

4.

Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma

5.

Health researchers discuss Medicaid cancer screening trends, best practices

1.

Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance

2.

The Different Types of Cysts and Why They Occur: Insights from a Dermatologist 

3.

Cold Antibody AIHA and Neoplastic Disorders: Unraveling the Clinical and Pathogenic Link

4.

Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance

5.

Cancer Stem Cells: The Seeds of Tumorigenesis and Recurrence

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part VIII

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

3.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

5.

Navigating the Complexities of Ph Negative ALL - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot